ABEO - Abeona Therapeutics Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
482
2,998
837
889
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
48,431
38,698
16,989
10,655
Selling General and Administrative
23,602
20,106
10,943
13,290
Total Operating Expenses
79,171
61,164
28,673
24,770
Operating Income or Loss
-78,689
-58,166
-27,836
-23,881
Interest Expense
2
11
8
6
Total Other Income/Expenses Net
-
-
-
0
Income Before Tax
-77,330
-56,671
-27,319
-21,873
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-77,330
-56,671
-27,319
-21,873
Net Income
-77,330
-56,671
-27,319
-21,873
Net Income available to common shareholders
-77,330
-56,671
-27,319
-21,873
Reported EPS
Basic
-
-1.19
-0.66
-0.64
Diluted
-
-1.19
-0.66
-0.64
Weighted average shares outstanding
Basic
-
47,528
41,637
34,180
Diluted
-
47,528
41,637
34,180
EBITDA
-
-54,300
-26,570
-21,042